Prognostic factors of severe Legionella pneumonia requiring admission to ICU

被引:74
作者
ElEbiary, M
Sarmiento, X
Torres, A
Nogue, S
Mesalles, E
Bodi, M
Almirall, J
机构
[1] UNIV BARCELONA, HOSP CLIN, SERV PNEUMOL & ALLERGIA RESP, DEPT MED, E-08036 BARCELONA, SPAIN
[2] AVI, HOSP CLIN, BARCELONA, SPAIN
[3] UCI, HOSP JOAN XXIII, TARRAGONA, SPAIN
[4] UCI, HOSP GERMANS TRIAS & PUJOL, BADALONA, SPAIN
关键词
D O I
10.1164/ajrccm.156.5.97-04039
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Despite the fact that the epidemiology of community-acquired pneumonia and nosocomial Legionella infection is well known, there are no specific reports dealing with severe cases of Legionella pneumophila pneumonia admitted to intensive care units. We undertook a prospective study upon 84 patients with a reliable diagnosis of L. pneumophila pneumonia that required ICU admission. The study assessed the prognostic factors, clinical, radiological and outcome variables of both nosocomial (n = 33) and community-acquired (n = 51) cases of L. pneumophila pneumonia. The following variables were more common in nosocomial acquired as compared to community-acquired Legionella pneumonia: Chronic obstructive pulmonary disease (COPD) (64 versus 41%), cardiac disease (39 versus 10%), chronic renal failure (21 versus 4%), alcoholism (54 versus 18%), septic shock (33 versus 16%), and unilateral chest X-ray involvement (61 versus 39%). The crude mortality rate in this study was 30% (25 of 84) with no differences when comparing mortality between nosocomial (9, 27%) to community-acquired (16, 31%) types. The univariate analysis showed that cardiac disease, diabetes mellitus, creatinine greater than or equal to 1.8 mg/dl, septic shock, chest X-ray extension, mechanical ventilation, hyponatremia less than or equal to 136 mEq/L, PA(CO2)/FIO2 < 130, and blood urea levels greater than or equal to 30 mg/dl were factors related to poor outcome. On the other hand, the following two variables were related to better outcome: adequate treatment for Legionella and pneumonia improvement. The logistic regression analysis demonstrated that APACHE II score > 15 at admission (RR: 11.5; 95% CI 1.75 to 76.1; p = 0.025), and serum Na levels less than or equal to 136 (RR: 21.3; 95% CI 1.11 to 408; p = 0.023), were the only independent factors related to death. On the other hand, improving pneumonia is associated with better outcome in Legionnaires' disease than for patients not having improving pneumonia (RR: 0.019; 95% CI: 0.036 to 0.106; p < 0.0001). A better understanding of the prognostic factors in cases of severe Legionella pneumonia will optimize our therapeutic approach in this disease and help to decrease both its mortality and morbidity rates.
引用
收藏
页码:1467 / 1472
页数:6
相关论文
共 27 条
[1]   Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit [J].
AlvarezLerma, F ;
Pellus, AM ;
Sanchez, BA ;
Ortiz, EP ;
Jorda, R ;
Barcenilla, F ;
Maravi, E ;
Galvan, B ;
Palomar, M ;
Serra, J ;
Bermejo, B ;
Mateu, A ;
Quintana, E ;
Palacios, MS ;
Giral, R ;
Gonzalez, V ;
Lerma, FA ;
Mesa, JL ;
Melgarejo, JA ;
Martinez, J ;
Insausti, J ;
Olaechea, P ;
Chanovas, M ;
Gilabert, A ;
Junquera, C ;
Valles, J ;
Palacios, F ;
Calvo, R ;
Mesalles, E ;
Nava, J ;
Santos, A ;
Armengol, S ;
Marzo, D .
INTENSIVE CARE MEDICINE, 1996, 22 (05) :387-394
[2]  
[Anonymous], 1991, MANUAL CLIN MICROBIO
[3]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[4]  
Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711
[5]   RISK-FACTORS FOR NOSOCOMIAL LEGIONELLA-PNEUMOPHILA PNEUMONIA [J].
CARRATALA, J ;
GUDIOL, F ;
PALLARES, R ;
DORCA, J ;
VERDAGUER, R ;
ARIZA, J ;
MANRESA, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :625-629
[6]   NOSOCOMIAL PNEUMONIA - A MULTIVARIATE-ANALYSIS OF RISK AND PROGNOSIS [J].
CELIS, R ;
TORRES, A ;
GATELL, JM ;
ALMELA, M ;
RODRIGUEZROISIN, R ;
AGUSTIVIDAL, A .
CHEST, 1988, 93 (02) :318-324
[7]   THE RISK OF DETERMINING RISK WITH MULTIVARIABLE MODELS [J].
CONCATO, J ;
FEINSTEIN, AR ;
HOLFORD, TR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) :201-210
[8]  
EDELSTEIN PH, 1980, AM REV RESPIR DIS, V121, P317
[9]   LEGIONELLA-PNEUMOPHILA - A CAUSE OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA [J].
FALCO, V ;
DESEVILLA, TF ;
ALEGRE, J ;
FERRER, A ;
VAZQUEZ, JMM .
CHEST, 1991, 100 (04) :1007-1011
[10]   NEW AND EMERGING ETIOLOGIES FOR COMMUNITY-ACQUIRED PNEUMONIA WITH IMPLICATIONS FOR THERAPY - A PROSPECTIVE MULTICENTER STUDY OF 359 CASES [J].
FANG, GD ;
FINE, M ;
ORLOFF, J ;
ARISUMI, D ;
YU, VL ;
KAPOOR, W ;
GRAYSTON, JT ;
WANG, SP ;
KOHLER, R ;
MUDER, RR ;
YEE, YC ;
RIHS, JD ;
VICKERS, RM .
MEDICINE, 1990, 69 (05) :307-316